Haemonetics Corporation - Asset Resilience Ratio

Latest as of December 2025: 14.59%

Haemonetics Corporation (HAE) has an Asset Resilience Ratio of 14.59% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$363.37 Million

Cash + Short-term Investments

Total Assets

$2.49 Billion

All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (1997–2025)

This chart shows how Haemonetics Corporation's Asset Resilience Ratio has changed over time. Check HAE PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Haemonetics Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see HAE market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$363.37 Million	14.59%
Short-term Investments	$0.00	0%
Total Liquid Assets	$363.37 Million	14.59%

Asset Resilience Insights

Moderate Liquidity: Haemonetics Corporation has 14.59% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Haemonetics Corporation Industry Peers by Asset Resilience Ratio

Compare Haemonetics Corporation's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
INKON Life Technology Co Ltd SHE:300143	Medical Devices	5.73%
Scibase AB ST:SCIB	Medical Devices	43.33%
T&L Co. Ltd KQ:340570	Medical Devices	33.68%
Tellgen Corp SHE:300642	Medical Devices	9.96%
Affluent Medical SAS PA:AFME	Medical Devices	0.03%
Vieworks Co. Ltd KQ:100120	Medical Devices	7.81%

Annual Asset Resilience Ratio for Haemonetics Corporation (1997–2025)

The table below shows the annual Asset Resilience Ratio data for Haemonetics Corporation.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	12.52%	$306.76 Million	$2.45 Billion	+4.30pp
2024-03-31	8.22%	$180.47 Million	$2.20 Billion	-6.54pp
2023-03-31	14.76%	$285.58 Million	$1.93 Billion	+0.81pp
2022-03-31	13.95%	$259.50 Million	$1.86 Billion	+3.39pp
2021-03-31	10.57%	$192.31 Million	$1.82 Billion	-0.27pp
2020-03-31	10.84%	$137.31 Million	$1.27 Billion	-2.45pp
2019-03-31	13.28%	$169.35 Million	$1.27 Billion	-1.28pp
2018-03-31	14.56%	$180.17 Million	$1.24 Billion	+3.29pp
2017-03-31	11.27%	$139.63 Million	$1.24 Billion	--
2016-03-31	0.00%	$0.00	$1.32 Billion	--
2015-03-31	0.00%	$0.00	$1.48 Billion	--
2014-03-31	0.08%	$1.25 Million	$1.52 Billion	--
2013-03-31	0.00%	$0.00	$1.46 Billion	--
2012-03-31	0.00%	$0.00	$910.63 Million	--
2011-03-31	0.00%	$0.00	$833.26 Million	--
2004-03-31	0.47%	$1.90 Million	$407.39 Million	-0.29pp
2003-03-31	0.75%	$2.70 Million	$359.21 Million	-8.19pp
2002-03-31	8.94%	$32.64 Million	$364.92 Million	-0.63pp
2001-03-31	9.57%	$33.04 Million	$345.31 Million	+7.28pp
2000-03-31	2.29%	$8.00 Million	$349.11 Million	-1.16pp
1999-03-31	3.45%	$12.30 Million	$356.40 Million	-0.08pp
1998-03-31	3.53%	$11.90 Million	$336.70 Million	-0.67pp
1997-03-31	4.20%	$13.60 Million	$323.50 Million	--

pp = percentage points

About Haemonetics Corporation

NYSE:HAE USA Medical Devices

Market Cap

$3.66 Billion

Market Cap Rank

#5450 Global

#1811 in USA

Share Price

$78.78

Change (1 day)

+1.78%

52-Week Range

$47.67 - $87.16

All Time High

$139.48